Alnylam Pharmaceuticals
ALNY
#639
Rank
$30.35 B
Marketcap
$234.56
Share price
1.76%
Change (1 day)
60.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company